Literature DB >> 19630730

Contingency management for smoking cessation: where do we go from here?

David M Ledgerwood1.   

Abstract

Each year, smoking-related illnesses are among the leading causes of preventable death in the U.S. and in many other countries. Although recently there have been substantial developments in pharmaceutical and behavioral smoking cessation treatments, these interventions do not work for all individuals, necessitating development of a wider array of treatments. Despite demonstrated efficacy in several studies, contingency management (CM) is a behavioral intervention that is not widely used as a smoking cessation treatment. This review surveys the current research literature on the efficacy of CM for smoking reduction, and identifies some of the most prominent barriers to wider implementation of CM as a stop-smoking treatment. Suggestions are made for future research to design behavioral smoking cessation programs that may be applied as a treatment for smokers in the community.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19630730     DOI: 10.2174/1874473710801030340

Source DB:  PubMed          Journal:  Curr Drug Abuse Rev        ISSN: 1874-4737


  21 in total

Review 1.  Contingency management interventions for tobacco and other substance use disorders in pregnancy.

Authors:  Dennis J Hand; Jennifer D Ellis; Meagan M Carr; Diane J Abatemarco; David M Ledgerwood
Journal:  Psychol Addict Behav       Date:  2017-06-22

2.  What does it cost to change behavior?

Authors:  Bruce A Christiansen
Journal:  Ann Fam Med       Date:  2012 May-Jun       Impact factor: 5.166

Review 3.  ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: implications for smoking and nicotine dependence.

Authors:  Scott H Kollins; R Alison Adcock
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-02-18       Impact factor: 5.067

Review 4.  Smoking Cessation for People Living With HIV/AIDS: A Literature Review and Synthesis.

Authors:  David M Ledgerwood; Russell Yskes
Journal:  Nicotine Tob Res       Date:  2016-05-31       Impact factor: 4.244

5.  Technology-based contingency management and e-cigarettes during the initial weeks of a smoking quit attempt.

Authors:  Sarah G Martner; Jesse Dallery
Journal:  J Appl Behav Anal       Date:  2019-10-02

6.  Rationale, design and pilot feasibility results of a smartphone-assisted, mindfulness-based intervention for smokers with mood disorders: Project mSMART MIND.

Authors:  Haruka Minami; Hannah R Brinkman; Shadi Nahvi; Julia H Arnsten; Monica Rivera-Mindt; David W Wetter; Erika Litvin Bloom; Lawrence H Price; Carlos Vieira; Remington Donnelly; Lauren M McClain; Katherine A Kennedy; Erica D'Aquila; Micki Fine; Danielle E McCarthy; J Graham Thomas; Jacki Hecht; Richard A Brown
Journal:  Contemp Clin Trials       Date:  2017-12-27       Impact factor: 2.226

7.  Prize contingency management for smoking cessation: a randomized trial.

Authors:  David M Ledgerwood; Cynthia L Arfken; Nancy M Petry; Sheila M Alessi
Journal:  Drug Alcohol Depend       Date:  2014-04-13       Impact factor: 4.492

Review 8.  Contingency management in substance abuse treatment: a structured review of the evidence for its transportability.

Authors:  Bryan Hartzler; Steve J Lash; John M Roll
Journal:  Drug Alcohol Depend       Date:  2011-12-09       Impact factor: 4.492

9.  A randomized trial of computer-delivered brief intervention and low-intensity contingency management for smoking during pregnancy.

Authors:  Steven J Ondersma; Dace S Svikis; Phebe K Lam; Veronica S Connors-Burge; David M Ledgerwood; John A Hopper
Journal:  Nicotine Tob Res       Date:  2011-12-09       Impact factor: 4.244

10.  Multicomponent smoking cessation treatment including mobile contingency management in homeless veterans.

Authors:  Vickie L Carpenter; Jeffrey S Hertzberg; Angela C Kirby; Patrick S Calhoun; Scott D Moore; Michelle F Dennis; Paul A Dennis; Eric A Dedert; Lauren P Hair; Jean C Beckham
Journal:  J Clin Psychiatry       Date:  2015-07       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.